Table 1 A bivariate analysis of demographic/clinical characteristics of lymphoma patients seen at Jos University Teaching Hospital from 01/01/2005 to 03/30/2015 by HIV status
From: Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria
| Â | HIV Negative N (%) | HIV Positive N (%) | Overall N (%) | P-value |
|---|---|---|---|---|
Number | 32 (80.0) | 8 (20.0) | 40 (100.0) | Â |
Gender, n (%) | ||||
 Male | 19 (59.4) | 6 (75.0) | 25 (62.5) | 0.41 |
 Female | 13 (40.6) | 2 (25.0) | 15 (37.5) | |
Age(yrs) | ||||
  ≤ 40 | 18 (56.3) | 2 (25.0) | 20 (50.0) | 0.11 |
  > 40 | 14 (43.8) | 6 (75.0) | 20 (50.0) | |
Age (Mean, SD) yrs | 39.78,15.27 | 46.38,11.46 | Â | 0.20 |
Histologic sub-type | ||||
 NHL | 28 (87.5) | 7 (87.5) | 35 (87.5) | 1.00 |
 HL | 4 (12.5) | 1 (12.5) | 5 (12.5) | |
Stage | ||||
 I & II | 22 (68.8) | 2 (25.0) | 24 (60.0) | 0.02 |
 III & IV | 10 (31.3) | 6 (75.0) | 16 (40.0) | |
Chemotherapy cycles | ||||
  > 4 | 21 (65.6) | 3 (37.5) | 24 (60.0) | 0.15 |
  ≤ 4 | 11 (34.4) | 5 (62.5) | 16 (40.0) | |
Comorbidity | ||||
 Absent | 18 (56.3) | 6 (75.0) | 24 (60.0) | 0.33 |
 Present | 14 (43.8) | 2 (25.0) | 16 (40.0) | |
Mortality (death) | ||||
 No deaths | 21 (65.6) | 3 (37.5) | 24 (60.0) | 0.15 |
 Deaths | 11 (34.4) | 5 (62.5) | 16 (40.0) | |
 Total Person years follow up | 10.85 | 116.78 | 127.63 | |
 Number of loss to Follow up | 2 | 0 |  | |